Wedbush Securities’s Verona Pharma VRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-2,385
Closed -$255K 1259
2025
Q3
$255K Sell
2,385
-300
-11% -$31.3K 0.01% 947
2025
Q2
$254K Sell
2,685
-475
-15% -$35.2K 0.01% 928
2025
Q1
$201K Buy
+3,160
New +$189K 0.01% 1011
2021
Q3
Sell
-18,035
Closed -$118K 1242
2021
Q2
$118K Sell
18,035
-3,965
-18% -$27.5K 0.01% 1117
2021
Q1
$184K Buy
22,000
+10,000
+83% +$83K 0.01% 997
2020
Q4
$84K Sell
12,000
-31,300
-72% -$211K 0.01% 844
2020
Q3
$270K Sell
43,300
-65,800
-60% -$455K 0.03% 661
2020
Q2
$511K Buy
109,100
+38,150
+54% +$177K 0.05% 422
2020
Q1
$292K Sell
70,950
-10,150
-13% -$55.7K 0.03% 532
2019
Q4
$466K Buy
81,100
+50,785
+168% +$222K 0.04% 503
2019
Q3
$139K Buy
30,315
+6,000
+25% +$26.8K 0.01% 866
2019
Q2
$124K Sell
24,315
-485
-2% -$2.96K 0.01% 883
2019
Q1
$161K Buy
24,800
+10,670
+76% +$69.5K 0.02% 813
2018
Q4
$127K Buy
+14,130
New +$160K 0.02% 738

Other funds holding VRNA